Managing Sialorrhea (Excessive Drooling) in Multiple System Atrophy
Sialorrhea — persistent excessive drooling — is a recognised and burdensome symptom in patients with multiple system atrophy. Its management requires a targeted approach distinct from the broader MSA treatment context.
Clinical scenario
Sialorrhea in MSA can arise from a combination of increased salivary secretion and impaired swallowing function. This protocol addresses that specific presentation, where drooling represents an active symptom requiring direct intervention.
Treatment approach
Anticholinergic therapy forms the basis of sialorrhea management in this setting. An oral systemic agent is a recognised option, though it must be used with careful attention to potential adverse effects. A local, sublingual alternative exists and may be preferred in certain patients due to a more favourable tolerability profile.
References
DOI: 10.1212/cont.0000000000001598
- Sialorrhea (ie, excessive drooling) can be a combination of excessive secretion from salivary glands and impaired swallowing function, as in progressive supranuclear palsy.
- Anticholinergic drugs such as oral glycopyrrolate may treat sialorrhea if applied with caution for potential side effects.
- Local anticholinergics (such as sublingual atropine drops) can be an alternative with fewer side effects.